Cytokines in aqueous humour and serum before and after corneal transplantation and during rejection

Ophthalmic Research

Volumn 32, Issue 4, 2000, Pages 157-164

  Van Gelderen, B E ^a   Van Der Lelij, A ^c   Peek, R ^a   Broersma, L ^a   Treffers, W F ^c   Ruijter, J M ^a,b   Van Der Gaag, R ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Aqueous humour; Cytokines; Keratitis, herpetic stromal; Keratoplasty, penetrating; Transplantation, corneal

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; PROTEIN;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORNEA TRANSPLANTATION; FEMALE; GRAFT REJECTION; HERPES SIMPLEX KERATITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 0034068286     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055607     Document Type: Article

References (35)

1. Williams KA, Muehlberg SM, Lewis RF, Coster DJ: How successful is corneal transplantation? A report from the Australian corneal graft register. Eye 1995;9:219-227.
2. Niederkorn JY, Mellon J: Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest Ophthalmol Vis Sci 1996;37:2700-2709.
3. Cousins SW, McCabe MM, Danielpour D, Streilein JW: Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humour. Invest Ophthalmol Vis Sci 1991;32:2201-2211.
4. Taylor AW, Streilein JW, Cousins SW: Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humour. Curr Eye Res 1992;11:1199-1206.
5. Taylor AW, Streilein JW, Cousins SW: Immunoreactive vasoactive intestinal peptide contributes to the immuno-suppressive activity of normal aqueous humour. J Immunol 1994;153:1080-1086.
6. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-1192.
7. Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA: CD96 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997;99(3):396-402.
8. Sano Y, Ksander BR, Streilein JW: Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Invest Ophthalmol Vis Sci 1995;36(11):2176-2185.
9. Li XY, D'Orazio LT, Niederkorn JY: Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology 1996;89:34-40.
10. Torres PF, de Vos AF, van der Gaag R, Martins B, Kijlstra A: Cytokine mRNA expression during experimental corneal allograft rejection. Exp Eye Res 1996;63:453-461.
11. Larkin DF, Calder VL, Lightman SL: Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection. Clin Exp Immunol 1997;107:381-391.
12. Pepose JS, Nestor MS, Gardner KM, Foos RY, Pettit TH: Composition of cellular infiltrates in rejected human corneal allografts. Graefe's Arch Clin Exp Ophthalmol 1985;222:128-133.
13. Wackenheim-Urlacher A, Kantelip B:T-cell repertoire of normal, rejected, and pathological corneas: Phenotype and function. Cornea 1995;14:450-456.
14. Nickerson P, Steiger J, Zheng XX, Steele AW, Steuerer W, Roy-Chaudhury P, Strain TB: Manipulation of cytokine networks in transplantation. False hope or realistic opportunity for tolerance? Transplantation 1997;63:489-494.
15. Chen N, Gao Q, Field EH: Prevention of Th1 responses is critical for tolerance. Transplantation 1996;61:1076-1083.
16. Macatonia SE, Doherty TM, Knight SC, O'Garra A: Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol 1993;150:3755-3765.
17. De Waal Malefyt R, Haanen J, Spits H: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915-924.
18. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
19. Boorstein SM, Elner SG, Meyer RF: Interleukin-10 inhibition of HLA-DR expression in human Herpes stromal keratitis. Ophthalmology 1994;101:1529-1535.
20. Küchle M, Vinores SA, Henderer JD, Green WD: Immunohistochemical evaluation of the integrity of the blood-aqueous barrier in normal and rubeotic human eyes. Invest Ophthalmol Vis Sci 1995;35:1595-1600.
21. Krams SM, Ascher NL, Martinez OM: New immunologic insights into mechanisms of allograft rejection. Gastroenterol Clin North Am 1993;22:381-400.
22. de Boer JH, van Haren MAC, de Vries-Knoppers WAEJ: Analysis of IL-6 levels in human vitreous fluid obtained from uveitis patients, patients with proliferative intraocular disorders and eye bank eyes. Curr Eye Res 1992;11(suppl):181-186.
23. Van der Lelij A, Rothova A: Diagnostic anterior chamber paracentesis in uveitis: A safe procedure? Br J Ophthalmol 1997;81:976-979.
24. Goldmann H, Witmer R: Antikörper im Kammerwasser. Ophthalmologica 1954;127:323-330.
25. de Boer JH, Luyendijk L, Rothova A: Detection of intraocular antibody production to herpesviruses in acute retinal necrosis syndrome. Am J Ophthalmol 1994;117:201-210.
26. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochcm 1976;62:248-254.
27. Babu JS, Kanangat S, Rouse BT: T-cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J Immunol 1995;154:4822-4829.
28. Rao G, Stevens RE, Harris JK, Aquavella JV: Long-term changes in corneal endothelium following intraocular lens implantation. Ophthalmology 1981;88:386-397.
29. Hardten DR: The cornea in cataract and intraocular lens surgery. Curr Opin Ophthalmol 1996;71:43-48.
30. Rosenbaum JT, Planck SR, Huang XN, Rich L, Ansel JC: Detection of mRNA for the cytokines, interleukin-1α and interleukin-8, in corneas form patients with pseudophakic bullous keratopathy. Invest Ophthalmol Vis Sci 1995;36:2151-2155.
31. Norose K, Yano A, Wang XC: Dominance of activated T-cells and interleukin-6 in aqueous humour in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 1994;35:33-39.
32. Loptain DE, Van Poperin N, MacCallum DK, Meyer RF, Lillie JH: Changes in aqueous immunoglobulin and albumin levels following penetrating keratoplasty. Invest Ophthalmol Vis Sci 1989;30:122-131.
33. Mottram PL, Han WR, Purcell LJ, McKenzie IFC, Hancock WW: Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and IFN-γ in long-surviving mouse heart allografts and brief CD4-monoclonal antibody therapy. Transplantation 1995;59:559-565.
34. Baan CC, Weimar W: Intragraft cytokine gene expression: Implications for clinical transplantation. Transplant Int 1998;11:169-180.
35. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 1990;11:165-190.